Qifa Liu, MD
Nanfang Hospital, Southern Medical University
9
9
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Qifa Liu
Nanfang Hospital, Southern Medical University
Shared therapeutic areas:
Worked with same sponsors:
Arnon Nagler, MD
Chaim Sheba Medical Center
Shared therapeutic areas:
Meral Boşnak Güçlü, PhD
Gazi University
Shared therapeutic areas:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Yves Beguin, MD, PhD
CHU-ULg
Shared therapeutic areas:
lei zhang, MD
Chinese Academy of Medical Science and Blood Disease Hospital
Shared therapeutic areas:
Worked with same sponsors:
He Huang, MD
First Affiliated Hospital of Zhejiang University
Shared therapeutic areas:
Worked with same sponsors:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Konrad E Bloch, MD
University Hospital, Zürich
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis
TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment
MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
MSC for Treatment of Interstitial Lung Disease After Allo-HSCT
All 9 trials loaded